Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Ibrutinib> ?p ?o }
- Ibrutinib abstract "Ibrutinib (USAN, also known as PCI-32765 and marketed under the name Imbruvica) is an anticancer drug targeting B-cell malignancies. It was approved by the US Food and Drug Administration (FDA) in November 2013 for the treatment of mantle cell lymphoma and in February 2014 for the treatment of chronic lymphocytic leukemia. It is an orally-administered, selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase (BTK). Ibrutinib is currently under development by Pharmacyclics, Inc and Johnson & Johnson's Janssen Pharmaceutical division for additional B-cell malignancies including diffuse large B-cell lymphoma and multiple myeloma. In January 2015, ibrutinib was approved by the FDA for treatment of Waldenström's macroglobulinemia, a form of non-Hogkins lymphoma.".
- Ibrutinib thumbnail Ibrutinib.svg?width=300.
- Ibrutinib wikiPageExternalLink ?CdrID=638648.
- Ibrutinib wikiPageExternalLink www.imbruvica.com.
- Ibrutinib wikiPageID "33997988".
- Ibrutinib wikiPageLength "13807".
- Ibrutinib wikiPageOutDegree "29".
- Ibrutinib wikiPageRevisionID "679573303".
- Ibrutinib wikiPageWikiLink Arthritis.
- Ibrutinib wikiPageWikiLink B-cell_chronic_lymphocytic_leukemia.
- Ibrutinib wikiPageWikiLink B-cell_malignancies.
- Ibrutinib wikiPageWikiLink Brutons_tyrosine_kinase.
- Ibrutinib wikiPageWikiLink CYP2D6.
- Ibrutinib wikiPageWikiLink CYP3A.
- Ibrutinib wikiPageWikiLink Category:Breakthrough_therapy.
- Ibrutinib wikiPageWikiLink Category:Experimental_cancer_drugs.
- Ibrutinib wikiPageWikiLink Category:Phenol_ethers.
- Ibrutinib wikiPageWikiLink Category:Piperidines.
- Ibrutinib wikiPageWikiLink Category:Tyrosine_kinase_inhibitors.
- Ibrutinib wikiPageWikiLink Celera_Corporation.
- Ibrutinib wikiPageWikiLink Celera_Genomics.
- Ibrutinib wikiPageWikiLink Chronic_lymphocytic_leukemia.
- Ibrutinib wikiPageWikiLink Creatinine.
- Ibrutinib wikiPageWikiLink Cysteine.
- Ibrutinib wikiPageWikiLink Diffuse_large_B-cell_lymphoma.
- Ibrutinib wikiPageWikiLink Drug_development.
- Ibrutinib wikiPageWikiLink Enzyme_inhibitor.
- Ibrutinib wikiPageWikiLink Food_and_Drug_Administration.
- Ibrutinib wikiPageWikiLink In_vivo.
- Ibrutinib wikiPageWikiLink Janssen_Pharmaceutica.
- Ibrutinib wikiPageWikiLink Janssen_Pharmaceutical.
- Ibrutinib wikiPageWikiLink Johnson_&_Johnson.
- Ibrutinib wikiPageWikiLink Lymphoid_leukemia.
- Ibrutinib wikiPageWikiLink Mantle_cell_lymphoma.
- Ibrutinib wikiPageWikiLink Michael_acceptor.
- Ibrutinib wikiPageWikiLink Michael_reaction.
- Ibrutinib wikiPageWikiLink Multiple_myeloma.
- Ibrutinib wikiPageWikiLink National_Cancer_Institute.
- Ibrutinib wikiPageWikiLink Thrombocytopaenia.
- Ibrutinib wikiPageWikiLink Thrombocytopenia.
- Ibrutinib wikiPageWikiLink US_Food_and_Drug_Administration.
- Ibrutinib wikiPageWikiLink United_States_Adopted_Name.
- Ibrutinib wikiPageWikiLink Waldenstrxc3xb6ms_macroglobulinemia.
- Ibrutinib wikiPageWikiLinkText "Ibrutinib".
- Ibrutinib wikiPageWikiLinkText "ibrutinib".
- Ibrutinib atcPrefix "L01".
- Ibrutinib atcSuffix "XE27".
- Ibrutinib c "25".
- Ibrutinib casNumber "936563".
- Ibrutinib chebi "76612".
- Ibrutinib chembl "1873475".
- Ibrutinib chemspiderid "26637187".
- Ibrutinib eliminationHalfLife "-21600.0".
- Ibrutinib excretion "Feces , urine".
- Ibrutinib h "24".
- Ibrutinib hasPhotoCollection Ibrutinib.
- Ibrutinib iupacName "1".
- Ibrutinib iupharLigand "6912".
- Ibrutinib legalUs "Rx-only".
- Ibrutinib licenceUs "Ibrutinib".
- Ibrutinib metabolism "Hepatic".
- Ibrutinib molecularWeight "440.4971".
- Ibrutinib n "6".
- Ibrutinib o "2".
- Ibrutinib pregnancyUs "D".
- Ibrutinib proteinBound "97.3".
- Ibrutinib pubchem "24821094".
- Ibrutinib smiles "C=CCN1CCC[C@H]N2C3=CCN".
- Ibrutinib stdinchi "1".
- Ibrutinib stdinchikey "XYFPWWZEPKGCCK-GOSISDBHBU".
- Ibrutinib tradename "Imbruvica".
- Ibrutinib width "200".
- Ibrutinib wikiPageUsesTemplate Template:Colbegin.
- Ibrutinib wikiPageUsesTemplate Template:Colend.
- Ibrutinib wikiPageUsesTemplate Template:Extracellular_chemotherapeutic_agents.
- Ibrutinib wikiPageUsesTemplate Template:Infobox_drug.
- Ibrutinib wikiPageUsesTemplate Template:Reflist.
- Ibrutinib subject Category:Breakthrough_therapy.
- Ibrutinib subject Category:Experimental_cancer_drugs.
- Ibrutinib subject Category:Phenol_ethers.
- Ibrutinib subject Category:Piperidines.
- Ibrutinib subject Category:Tyrosine_kinase_inhibitors.
- Ibrutinib hypernym Drug.
- Ibrutinib type Article.
- Ibrutinib type ChemicalSubstance.
- Ibrutinib type Drug.
- Ibrutinib type Article.
- Ibrutinib type Drug.
- Ibrutinib type Ether.
- Ibrutinib type Heterocycle.
- Ibrutinib type Inhibitor.
- Ibrutinib type ChemicalObject.
- Ibrutinib type Thing.
- Ibrutinib type Q8386.
- Ibrutinib comment "Ibrutinib (USAN, also known as PCI-32765 and marketed under the name Imbruvica) is an anticancer drug targeting B-cell malignancies. It was approved by the US Food and Drug Administration (FDA) in November 2013 for the treatment of mantle cell lymphoma and in February 2014 for the treatment of chronic lymphocytic leukemia. It is an orally-administered, selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase (BTK).".
- Ibrutinib label "Ibrutinib".
- Ibrutinib sameAs Ibrutinib.
- Ibrutinib sameAs Ibrutinib.
- Ibrutinib sameAs ایبروتینیب.
- Ibrutinib sameAs Ibrutinib.